{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T15:44:51Z","timestamp":1777045491347,"version":"3.51.4"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,10,15]],"date-time":"2014-10-15T00:00:00Z","timestamp":1413331200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2407-14-766","type":"journal-article","created":{"date-parts":[[2014,10,15]],"date-time":"2014-10-15T09:02:41Z","timestamp":1413363761000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Chemically induced mouse liver tumors are resistant to treatment with atorvastatin"],"prefix":"10.1186","volume":"14","author":[{"given":"Albert","family":"Braeuning","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Bucher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ute","family":"Hofmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albrecht","family":"Buchmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,10,15]]},"reference":[{"issue":"1","key":"4942_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2012.04.011","volume":"324","author":"M Osmak","year":"2012","unstructured":"Osmak M: Statins and cancer: current and future prospects. Cancer Lett. 2012, 324 (1): 1-12. 10.1016\/j.canlet.2012.04.011.","journal-title":"Cancer Lett"},{"issue":"7","key":"4942_CR2","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1093\/annonc\/mdt150","volume":"24","author":"PP Singh","year":"2012","unstructured":"Singh PP, Singh S: Statins are associated with reduced risk of gastric cancer: a systematic review and meta-analysis. Ann Oncol. 2012, 24 (7): 1721-1730.","journal-title":"Ann Oncol"},{"issue":"2","key":"4942_CR3","doi-asserted-by":"publisher","first-page":"176","DOI":"10.4103\/0973-1482.98967","volume":"8","author":"S Zeichner","year":"2012","unstructured":"Zeichner S, Mihos CG, Santana O: The pleiotropic effects and therapeutic potential of the hydroxy-methyl-glutaryl-CoA reductase inhibitors in malignancies: a comprehensive review. J Cancer Res Ther. 2012, 8 (2): 176-183. 10.4103\/0973-1482.98967.","journal-title":"J Cancer Res Ther"},{"issue":"13","key":"4942_CR4","doi-asserted-by":"publisher","first-page":"3524","DOI":"10.1158\/1078-0432.CCR-12-0489","volume":"18","author":"M Thurnher","year":"2012","unstructured":"Thurnher M, Nussbaumer O, Gruenbacher G: Novel aspects of mevalonate pathway inhibitors as antitumor agents. Clin Cancer Res. 2012, 18 (13): 3524-3531. 10.1158\/1078-0432.CCR-12-0489.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"4942_CR5","doi-asserted-by":"publisher","first-page":"e29849","DOI":"10.1371\/journal.pone.0029849","volume":"7","author":"JR Emberson","year":"2012","unstructured":"Emberson JR, Kearney PM, Blackwell L, Newman C, Reith C, Bhala N, Holland L, Peto R, Keech A, Collins R, Simes J, Baigent C: Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy. PLoS One. 2012, 7 (1): e29849-10.1371\/journal.pone.0029849.","journal-title":"PLoS One"},{"issue":"30","key":"4942_CR6","doi-asserted-by":"publisher","first-page":"4808","DOI":"10.1200\/JCO.2006.06.3560","volume":"24","author":"S Bonovas","year":"2006","unstructured":"Bonovas S, Filioussi K, Tsavaris N, Sitaras NM: Statins and cancer risk: a literature-based meta-analysis and meta-regression analysis of 35 randomized controlled trials. J Clin Oncol. 2006, 24 (30): 4808-4817. 10.1200\/JCO.2006.06.3560.","journal-title":"J Clin Oncol"},{"issue":"15","key":"4942_CR7","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1016\/j.ejca.2008.06.025","volume":"44","author":"J Kuoppala","year":"2008","unstructured":"Kuoppala J, Lamminpaa A, Pukkala E: Statins and cancer: A systematic review and meta-analysis. Eur J Cancer. 2008, 44 (15): 2122-2132. 10.1016\/j.ejca.2008.06.025.","journal-title":"Eur J Cancer"},{"issue":"12","key":"4942_CR8","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1200\/JCO.2012.44.6831","volume":"31","author":"YT Tsan","year":"2013","unstructured":"Tsan YT, Lee CH, Ho WC, Lin MH, Wang JD, Chen PC: Statins and the risk of hepatocellular carcinoma in patients with hepatitis C virus infection. J Clin Oncol. 2013, 31 (12): 1514-1521. 10.1200\/JCO.2012.44.6831.","journal-title":"J Clin Oncol"},{"issue":"6","key":"4942_CR9","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1200\/JCO.2011.36.0917","volume":"30","author":"YT Tsan","year":"2012","unstructured":"Tsan YT, Lee CH, Wang JD, Chen PC: Statins and the risk of hepatocellular carcinoma in patients with hepatitis B virus infection. J Clin Oncol. 2012, 30 (6): 623-630. 10.1200\/JCO.2011.36.0917.","journal-title":"J Clin Oncol"},{"issue":"3","key":"4942_CR10","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1097\/CEJ.0b013e328358761a","volume":"22","author":"D Pradelli","year":"2013","unstructured":"Pradelli D, Soranna D, Scotti L, Zambon A, Catapano A, Mancia G, La Vecchia C, Corrao G: Statins and primary liver cancer: a meta-analysis of observational studies. Eur J Cancer Prev. 2013, 22 (3): 229-234. 10.1097\/CEJ.0b013e328358761a.","journal-title":"Eur J Cancer Prev"},{"issue":"1","key":"4942_CR11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1517\/14740338.2013.744392","volume":"12","author":"HW Leung","year":"2013","unstructured":"Leung HW, Chan AL, Lo D, Leung JH, Chen HL: Common cancer risk and statins: a population-based case\u2013control study in a Chinese population. Expert Opin Drug Saf. 2013, 12 (1): 19-27. 10.1517\/14740338.2013.744392.","journal-title":"Expert Opin Drug Saf"},{"issue":"6","key":"4942_CR12","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s10654-013-9806-y","volume":"28","author":"SW Lai","year":"2013","unstructured":"Lai SW, Liao KF, Lai HC, Muo CH, Sung FC, Chen PC: Statin use and risk of hepatocellular carcinoma. Eur J Epidemiol. 2013, 28 (6): 485-492. 10.1007\/s10654-013-9806-y.","journal-title":"Eur J Epidemiol"},{"issue":"11","key":"4942_CR13","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1111\/j.1440-1746.2012.07232.x","volume":"27","author":"A Lonardo","year":"2012","unstructured":"Lonardo A, Loria P: Potential for statins in the chemoprevention and management of hepatocellular carcinoma. J Gastroenterol Hepatol. 2012, 27 (11): 1654-1664. 10.1111\/j.1440-1746.2012.07232.x.","journal-title":"J Gastroenterol Hepatol"},{"issue":"5","key":"4942_CR14","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1053\/j.gastro.2009.01.053","volume":"136","author":"HB El-Serag","year":"2009","unstructured":"El-Serag HB, Johnson ML, Hachem C, Morgana RO: Statins are associated with a reduced risk of hepatocellular carcinoma in a large cohort of patients with diabetes. Gastroenterology. 2009, 136 (5): 1601-1608. 10.1053\/j.gastro.2009.01.053.","journal-title":"Gastroenterology"},{"issue":"2","key":"4942_CR15","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1053\/j.gastro.2012.10.005","volume":"144","author":"S Singh","year":"2013","unstructured":"Singh S, Singh PP, Singh AG, Murad MH, Sanchez W: Statins are associated with a reduced risk of hepatocellular cancer: a systematic review and meta-analysis. Gastroenterology. 2013, 144 (2): 323-332. 10.1053\/j.gastro.2012.10.005.","journal-title":"Gastroenterology"},{"issue":"32","key":"4942_CR16","doi-asserted-by":"publisher","first-page":"4160","DOI":"10.1200\/JCO.2013.50.9208","volume":"31","author":"S Bonovas","year":"2013","unstructured":"Bonovas S, Nikolopoulos G, Sitaras NM: Statins and reduced risk of hepatocellular carcinoma in patients with hepatitis C virus infection: further evidence is warranted. J Clin Oncol. 2013, 31 (32): 4160-","journal-title":"J Clin Oncol"},{"issue":"32","key":"4942_CR17","doi-asserted-by":"publisher","first-page":"4161","DOI":"10.1200\/JCO.2013.51.5593","volume":"31","author":"JL Lund","year":"2013","unstructured":"Lund JL, Montomoli J: Common flaws in pharmacoepidemiologic study design and analysis. J Clin Oncol. 2013, 31 (32): 4161-4162. 10.1200\/JCO.2013.51.5593.","journal-title":"J Clin Oncol"},{"issue":"32","key":"4942_CR18","doi-asserted-by":"publisher","first-page":"4160","DOI":"10.1200\/JCO.2013.51.0354","volume":"31","author":"S Clement","year":"2013","unstructured":"Clement S, Peyrou M, Foti M, Negro F: Statins may protect against hepatocellular carcinoma development in patients infected with hepatitis C virus, but what are the mechanisms?. J Clin Oncol. 2013, 31 (32): 4160-4161.","journal-title":"J Clin Oncol"},{"issue":"1","key":"4942_CR19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.clinre.2013.09.007","volume":"38","author":"F Carrat","year":"2014","unstructured":"Carrat F: Statin and aspirin for prevention of hepatocellular carcinoma: What are the levels of evidence?. Clin Res Hepatol Gastroenterol. 2014, 38 (1): 9-11. 10.1016\/j.clinre.2013.09.007.","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"20","key":"4942_CR20","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1200\/JCO.2012.43.2179","volume":"30","author":"PP Singh","year":"2012","unstructured":"Singh PP, Singh S: Statins and risk reduction in hepatocellular carcinoma: fact or fiction?. J Clin Oncol. 2012, 30 (20): 2569-2570. 10.1200\/JCO.2012.43.2179. author reply 2570\u20132571","journal-title":"J Clin Oncol"},{"issue":"3","key":"4942_CR21","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.3892\/or.2012.1860","volume":"28","author":"J Kah","year":"2012","unstructured":"Kah J, Wustenberg A, Keller AD, Sirma H, Montalbano R, Ocker M, Volz T, Dandri M, Tiegs G, Sass G: Selective induction of apoptosis by HMG-CoA reductase inhibitors in hepatoma cells and dependence on p53 expression. Oncol Rep. 2012, 28 (3): 1077-1083.","journal-title":"Oncol Rep"},{"issue":"5","key":"4942_CR22","doi-asserted-by":"publisher","first-page":"735","DOI":"10.3892\/ijmm_00000520","volume":"26","author":"B Relja","year":"2010","unstructured":"Relja B, Meder F, Wilhelm K, Henrich D, Marzi I, Lehnert M: Simvastatin inhibits cell growth and induces apoptosis and G0\/G1 cell cycle arrest in hepatic cancer cells. Int J Mol Med. 2010, 26 (5): 735-741.","journal-title":"Int J Mol Med"},{"issue":"12","key":"4942_CR23","first-page":"1167","volume":"48","author":"W Zhang","year":"2010","unstructured":"Zhang W, Wu J, Zhou L, Xie HY, Zheng SS: Fluvastatin, a lipophilic statin, induces apoptosis in human hepatocellular carcinoma cells through mitochondria-operated pathway. Indian J Exp Biol. 2010, 48 (12): 1167-1174.","journal-title":"Indian J Exp Biol"},{"issue":"19","key":"4942_CR24","doi-asserted-by":"publisher","first-page":"7699","DOI":"10.1158\/0008-5472.CAN-10-1626","volume":"70","author":"PM Yang","year":"2010","unstructured":"Yang PM, Liu YL, Lin YC, Shun CT, Wu MS, Chen CC: Inhibition of autophagy enhances anticancer effects of atorvastatin in digestive malignancies. Cancer Res. 2010, 70 (19): 7699-7709. 10.1158\/0008-5472.CAN-10-1626.","journal-title":"Cancer Res"},{"issue":"6","key":"4942_CR25","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1158\/0008-5472.CAN-10-3367","volume":"71","author":"Z Cao","year":"2011","unstructured":"Cao Z, Fan-Minogue H, Bellovin DI, Yevtodiyenko A, Arzeno J, Yang Q, Gambhir SS, Felsher DW: MYC phosphorylation, activation, and tumorigenic potential in hepatocellular carcinoma are regulated by HMG-CoA reductase. Cancer Res. 2011, 71 (6): 2286-2297. 10.1158\/0008-5472.CAN-10-3367.","journal-title":"Cancer Res"},{"key":"4942_CR26","doi-asserted-by":"publisher","first-page":"640797","DOI":"10.1155\/2010\/640797","volume":"2010","author":"A Tijeras-Raballand","year":"2010","unstructured":"Tijeras-Raballand A, Hainaud-Hakim P, Contreres JO, Gest C, Le Henaff C, Levy BI, Pocard M, Soria C, Dupuy E: Rosuvastatin counteracts vessel arterialisation and sinusoid capillarisation, reduces tumour growth, and prolongs survival in murine hepatocellular carcinoma. Gastroenterol Res Pract. 2010, 2010: 640797-","journal-title":"Gastroenterol Res Pract"},{"key":"4942_CR27","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/1471-2407-11-281","volume":"11","author":"M Shimizu","year":"2011","unstructured":"Shimizu M, Yasuda Y, Sakai H, Kubota M, Terakura D, Baba A, Ohno T, Kochi T, Tsurumi H, Tanaka T, Moriwaki H: Pitavastatin suppresses diethylnitrosamine-induced liver preneoplasms in male C57BL\/KsJ-db\/db obese mice. BMC Cancer. 2011, 11: 281-10.1186\/1471-2407-11-281.","journal-title":"BMC Cancer"},{"issue":"4","key":"4942_CR28","first-page":"1105","volume":"30","author":"L Bjorkhem-Bergman","year":"2010","unstructured":"Bjorkhem-Bergman L, Acimovic J, Torndal UB, Parini P, Eriksson LC: Lovastatin prevents carcinogenesis in a rat model for liver cancer. Effects of ubiquinone supplementation. Anticancer Res. 2010, 30 (4): 1105-1112.","journal-title":"Anticancer Res"},{"issue":"7","key":"4942_CR29","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1158\/1535-7163.MCT-09-0055","volume":"8","author":"GA Finlay","year":"2009","unstructured":"Finlay GA, Malhowski AJ, Polizzi K, Malinowska-Kolodziej I, Kwiatkowski DJ: Renal and liver tumors in Tsc2(+\/-) mice, a model of tuberous sclerosis complex, do not respond to treatment with atorvastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor. Mol Cancer Ther. 2009, 8 (7): 1799-1807. 10.1158\/1535-7163.MCT-09-0055.","journal-title":"Mol Cancer Ther"},{"issue":"4","key":"4942_CR30","doi-asserted-by":"crossref","first-page":"635","DOI":"10.18388\/abp.2011_2235","volume":"58","author":"A Leszczynska","year":"2011","unstructured":"Leszczynska A, Gora M, Plochocka D, Hoser G, Szkopinska A, Koblowska M, Iwanicka-Nowicka R, Kotlinski M, Rawa K, Kiliszek M, Burzynska B: Different statins produce highly divergent changes in gene expression profiles of human hepatoma cells: a pilot study. Acta Biochim Pol. 2011, 58 (4): 635-639.","journal-title":"Acta Biochim Pol"},{"issue":"1","key":"4942_CR31","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1006\/bbrc.1997.6840","volume":"236","author":"CM Schmidt","year":"1997","unstructured":"Schmidt CM, McKillop IH, Cahill PA, Sitzmann JV: Increased MAPK expression and activity in primary human hepatocellular carcinoma. Biochem Biophys Res Commun. 1997, 236 (1): 54-58. 10.1006\/bbrc.1997.6840.","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"4942_CR32","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1002\/ijc.22801","volume":"121","author":"M Jaworski","year":"2007","unstructured":"Jaworski M, Ittrich C, Hailfinger S, Bonin M, Buchmann A, Schwarz M, Kohle C: Global gene expression in Ha-ras and B-raf mutated mouse liver tumors. Int J Cancer. 2007, 121 (6): 1382-1385. 10.1002\/ijc.22801.","journal-title":"Int J Cancer"},{"issue":"7","key":"4942_CR33","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1002\/ijc.28798","volume":"135","author":"EB Unterberger","year":"2014","unstructured":"Unterberger EB, Eichner J, Wrzodek C, Lempiainen H, Luisier R, Terranova R, Metzger U, Plummer S, Knorpp T, Braeuning A, Moggs J, Templin MF, Honndorf V, Piotto M, Zell A, Schwarz M: Ha-ras and beta-Catenin oncoproteins orchestrate metabolic programs in mouse liver tumors. Int J Cancer. 2014, 135 (7): 1574-1585. 10.1002\/ijc.28798.","journal-title":"Int J Cancer"},{"issue":"18","key":"4942_CR34","first-page":"5087","volume":"60","author":"O Moennikes","year":"2000","unstructured":"Moennikes O, Buchmann A, Romualdi A, Ott T, Werringloer J, Willecke K, Schwarz M: Lack of phenobarbital-mediated promotion of hepatocarcinogenesis in connexin32-null mice. Cancer Res. 2000, 60 (18): 5087-5091.","journal-title":"Cancer Res"},{"issue":"8","key":"4942_CR35","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1007\/s00204-013-1030-8","volume":"87","author":"Y Singh","year":"2013","unstructured":"Singh Y, Braeuning A, Schmid A, Pichler BJ, Schwarz M: Selective poisoning of Ctnnb1-mutated hepatoma cells in mouse liver tumors by a single application of acetaminophen. Arch Toxicol. 2013, 87 (8): 1595-1607. 10.1007\/s00204-013-1030-8.","journal-title":"Arch Toxicol"},{"issue":"1","key":"4942_CR36","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/ajcp\/27.1.13","volume":"27","author":"M Wachstein","year":"1957","unstructured":"Wachstein M, Meisel E: Histochemistry of hepatic phosphatases of a physiologic pH; with special reference to the demonstration of bile canaliculi. Am J Clin Pathol. 1957, 27 (1): 13-23.","journal-title":"Am J Clin Pathol"},{"issue":"11","key":"4942_CR37","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/S0022-2275(20)41640-2","volume":"32","author":"F Czubayko","year":"1991","unstructured":"Czubayko F, Beumers B, Lammsfuss S, Lutjohann D, von Bergmann K: A simplified micro-method for quantification of fecal excretion of neutral and acidic sterols for outpatient studies in humans. J Lipid Res. 1991, 32 (11): 1861-1867.","journal-title":"J Lipid Res"},{"issue":"1","key":"4942_CR38","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1006\/abio.1995.1110","volume":"225","author":"S Dzeletovic","year":"1995","unstructured":"Dzeletovic S, Breuer O, Lund E, Diczfalusy U: Determination of cholesterol oxidation products in human plasma by isotope dilution-mass spectrometry. Anal Biochem. 1995, 225 (1): 73-80. 10.1006\/abio.1995.1110.","journal-title":"Anal Biochem"},{"issue":"3","key":"4942_CR39","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.taap.2012.11.018","volume":"266","author":"MC Podszun","year":"2013","unstructured":"Podszun MC, Grebenstein N, Hofmann U, Frank J: High-dose supplementation with natural alpha-tocopherol does neither alter the pharmacodynamics of atorvastatin nor its phase I metabolism in guinea pigs. Toxicol Appl Pharmacol. 2013, 266 (3): 452-458. 10.1016\/j.taap.2012.11.018.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"2","key":"4942_CR40","first-page":"465","volume":"42","author":"HA Campbell","year":"1982","unstructured":"Campbell HA, Pitot HC, Potter VR, Laishes BA: Application of quantitative stereology to the evaluation of enzyme-altered foci in rat liver. Cancer Res. 1982, 42 (2): 465-472.","journal-title":"Cancer Res"},{"issue":"1\u20132","key":"4942_CR41","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.mrfmmm.2007.08.015","volume":"638","author":"A Buchmann","year":"2008","unstructured":"Buchmann A, Karcier Z, Schmid B, Strathmann J, Schwarz M: Differential selection for B-raf and Ha-ras mutated liver tumors in mice with high and low susceptibility to hepatocarcinogenesis. Mutat Res. 2008, 638 (1\u20132): 66-74.","journal-title":"Mutat Res"},{"issue":"18","key":"4942_CR42","doi-asserted-by":"publisher","first-page":"4766","DOI":"10.1111\/j.1742-4658.2007.06002.x","volume":"274","author":"A Braeuning","year":"2007","unstructured":"Braeuning A, Menzel M, Kleinschnitz EM, Harada N, Tamai Y, Kohle C, Buchmann A, Schwarz M: Serum components and activated Ha-ras antagonize expression of perivenous marker genes stimulated by beta-catenin signaling in mouse hepatocytes. Febs J. 2007, 274 (18): 4766-4777. 10.1111\/j.1742-4658.2007.06002.x.","journal-title":"Febs J"},{"issue":"9","key":"4942_CR43","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1007\/s00204-012-0841-3","volume":"86","author":"A Braeuning","year":"2012","unstructured":"Braeuning A, Vetter S, Orsetti S, Schwarz M: Paradoxical cytotoxicity of tert-butylhydroquinone in vitro: What kills the untreated cells?. Arch Toxicol. 2012, 86 (9): 1481-1487. 10.1007\/s00204-012-0841-3.","journal-title":"Arch Toxicol"},{"issue":"13","key":"4942_CR44","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1093\/jnci\/82.13.1107","volume":"82","author":"P Skehan","year":"1990","unstructured":"Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S, Boyd MR: New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst. 1990, 82 (13): 1107-1112. 10.1093\/jnci\/82.13.1107.","journal-title":"J Natl Cancer Inst"},{"issue":"9","key":"4942_CR45","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","volume":"29","author":"MW Pfaffl","year":"2001","unstructured":"Pfaffl MW: A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001, 29 (9): e45-10.1093\/nar\/29.9.e45.","journal-title":"Nucleic Acids Res"},{"issue":"23 Suppl 1","key":"4942_CR46","first-page":"III50","volume":"109","author":"S Bellosta","year":"2004","unstructured":"Bellosta S, Paoletti R, Corsini A: Safety of statins: focus on clinical pharmacokinetics and drug interactions. Circulation. 2004, 109 (23 Suppl 1): III50-III57.","journal-title":"Circulation"},{"issue":"7","key":"4942_CR47","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1124\/dmd.107.019455","volume":"36","author":"SW Paine","year":"2008","unstructured":"Paine SW, Parker AJ, Gardiner P, Webborn PJ, Riley RJ: Prediction of the pharmacokinetics of atorvastatin, cerivastatin, and indomethacin using kinetic models applied to isolated rat hepatocytes. Drug Metab Dispos. 2008, 36 (7): 1365-1374. 10.1124\/dmd.107.019455.","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"4942_CR48","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/hep.21082","volume":"43","author":"S Hailfinger","year":"2006","unstructured":"Hailfinger S, Jaworski M, Braeuning A, Buchmann A, Schwarz M: Zonal gene expression in murine liver: Lessons from tumors. Hepatology. 2006, 43 (3): 407-414. 10.1002\/hep.21082.","journal-title":"Hepatology"},{"issue":"2","key":"4942_CR49","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1124\/jpet.105.093088","volume":"316","author":"YY Lau","year":"2006","unstructured":"Lau YY, Okochi H, Huang Y, Benet LZ: Multiple transporters affect the disposition of atorvastatin and its two active hydroxy metabolites: application of in vitro and ex situ systems. J Pharmacol Exp Ther. 2006, 316 (2): 762-771.","journal-title":"J Pharmacol Exp Ther"},{"issue":"25 Pt B","key":"4942_CR50","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1016\/j.jacc.2013.11.002","volume":"63","author":"NJ Stone","year":"2014","unstructured":"Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, Goldberg AC, Gordon D, Levy D, Lloyd-Jones DM, McBride P, Schwartz JS, Shero ST, Smith SC, Watson K, Wilson PW: 2013 ACC\/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014, 63 (25 Pt B): 2889-2934.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"4942_CR51","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1023\/A:1020884312053","volume":"32","author":"AA Bachmanov","year":"2002","unstructured":"Bachmanov AA, Reed DR, Beauchamp GK, Tordoff MG: Food intake, water intake, and drinking spout side preference of 28 mouse strains. Behav Genet. 2002, 32 (6): 435-443. 10.1023\/A:1020884312053.","journal-title":"Behav Genet"},{"issue":"9","key":"4942_CR52","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1080\/00498250802334391","volume":"38","author":"JE Park","year":"2008","unstructured":"Park JE, Kim KB, Bae SK, Moon BS, Liu KH, Shin JG: Contribution of cytochrome P450 3A4 and 3A5 to the metabolism of atorvastatin. Xenobiotica. 2008, 38 (9): 1240-1251. 10.1080\/00498250802334391.","journal-title":"Xenobiotica"},{"issue":"9","key":"4942_CR53","doi-asserted-by":"publisher","first-page":"801","DOI":"10.4161\/cbt.11.9.15176","volume":"11","author":"K Wlcek","year":"2011","unstructured":"Wlcek K, Svoboda M, Riha J, Zakaria S, Olszewski U, Dvorak Z, Sellner F, Ellinger I, Jager W, Thalhammer T: The analysis of organic anion transporting polypeptide (OATP) mRNA and protein patterns in primary and metastatic liver cancer. Cancer Biol Ther. 2011, 11 (9): 801-811. 10.4161\/cbt.11.9.15176.","journal-title":"Cancer Biol Ther"},{"issue":"3","key":"4942_CR54","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1148\/radiol.10091557","volume":"255","author":"T Tsuboyama","year":"2010","unstructured":"Tsuboyama T, Onishi H, Kim T, Akita H, Hori M, Tatsumi M, Nakamoto A, Nagano H, Matsuura N, Wakasa K, Tomoda K: Hepatocellular carcinoma: hepatocyte-selective enhancement at gadoxetic acid-enhanced MR imaging\u2013correlation with expression of sinusoidal and canalicular transporters and bile accumulation. Radiology. 2010, 255 (3): 824-833. 10.1148\/radiol.10091557.","journal-title":"Radiology"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-766.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-14-766\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-766","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T00:08:48Z","timestamp":1650413328000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-14-766"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,15]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["4942"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-14-766","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,15]]},"article-number":"766"}}